CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Zhongyuan Union Cell & Gene Engineering Corp Ltd Company Snapshot
Zhongyuan Union Cell & Gene Engineering Corp Ltd operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zhongyuan Union Cell & Gene Engineering Corp Ltd with three other companies in this sector in China: Beijing SL Pharmaceutical Co Ltd (2016 sales of 1.01 billion Chinese Renmimbi [US$151.04 million] of which 98% was Pharmaceuticals Industry), Boya Bio pharmaceutical Group Co Ltd (946.57 million Chinese Renmimbi [US$141.58 million] of which 56% was Blood Plasma), and Tianjin Ringpu Bio-Technology Co Ltd (969.68 million Chinese Renmimbi [US$145.04 million] of which 63% was Veterinary Biological Products).

Sales Analysis. During the year ended December of 2016, sales at Zhongyuan Union Cell & Gene Engineering Corp Ltd were 835.64 million Chinese Renmimbi (US$124.99 million). This is an increase of 18.2% versus 2015, when the company's sales were 706.86 million Chinese Renmimbi. This was the fifth consecutive year of sales increases at Zhongyuan Union Cell & Gene Engineering Corp Ltd (and since 2011, sales have increased a total of 239%). Sales of Detection Reagent saw an increase of 24.4% in 2016, from 249.98 million Chinese Renmimbi to 310.87 million Chinese Renmimbi. Not all segments of Zhongyuan Union Cell & Gene Engineering Corp Ltd experienced an increase in sales in 2016: sales of Cosmetics Manufacturing fell 85.8% to 1.02 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). Zhongyuan Union Cell & Gene Engineering Corp Ltd also experienced decreases in sales in Other Operations (down 44.9% to 14.51 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Zhongyuan Union Cell & Gene Engineering Corp Ltd
  Stock Performance Chart for Zhongyuan Union Cell & Gene Engineering Corp Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (8/11/2017): 22.12
(Figures in Chinese Renmimbi)
1 Week -0.9%   13 Weeks -6.6%  
4 Weeks 10.8%   52 Weeks -33.3%  
 
Zhongyuan Union Cell & Gene Engineering Corp Ltd Key Data:
  Ticker: 600645 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 835,636,405
(Year Ending Jan 2017).
Employees: 1,860
  Currency: Chinese Renmimbi Market Cap: 8,540,339,866
  Fiscal Yr Ends: December Shares Outstanding: 386,091,314
  Share Type: A Gu Closely Held Shares: 124,768,265
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.